Denmark to continuing banning J&J AstraZeneca vaccines
For this year Astrazeneca 's (located in Cambridge) revenue will be around 31.97 billion GBp. This is according to the average of the analysts' estimates. This is hugely more than 2020's revenue of 26.62 billion GBp.
Historical revenues and results Astrazeneca plus estimates 2020
The analysts expect for 2021 a net profit of 6.97 billion GBp. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 515 GBp. So the price/earnings-ratio equals 16.93.
Huge dividend Astrazeneca
For this year the analysts expect a dividend of 283 GBp per share. Astrazeneca 's dividend yield thus equals 3.25 percent. The average dividend yield of the pharmaceutical companies equals a limited 1.39 percent.Most recent target prices around 8333 GBp
The most recent recommendations for the pharmaceutical company are from UBS , Goldman Sachs and Credit Suisse .Based on the current number of shares Astrazeneca 's market capitalization equals 11443.16 billion GBp. The Astrazeneca stock was the past 12 months quite unstable. Since last July the stock is 5 percent higher. This year the stock price moved between 6500 and 10120 GBp.
Historical stock prices Astrazeneca
At 18.09 the stock trades 0.72 percent lower at 8721 GBp.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
